Received Mar 18, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TYP | TYPHOID LIVE ORAL TY21A (VIVOTIF) | BERNA BIOTECH, LTD. | 1 | Unknown | PO / MO |
The patient took the first Vivotif capsule with hot coffee; Case reference number US-BN-2025-000904 is a spontaneous case initially received from pharmacist via Communications (reference number: USBAV25-1015) on 02-May-2025 and concerns a female patient of unspecified age. The patient's medical history and concomitant medication details were not provided. On 02-May-2025, reported as today, the patient took the first dose of Vivotif vaccine with hot coffee (batch number: unknown) at a dose of one capsule, orally for indication typhoid fever prophylaxis (explicitly coded as 'product administration error') At the time of initial report, it was unknown if the patient experienced any adverse event due to Vivotif vaccine. No further information was provided.; Reporter's Comments: A female patient of unspecified age took the first dose of Vivotif vaccine with hot coffee for indication typhoid fever prophylaxis, which is considered as product administration error. It was unknown if the patient experienced any of adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.; Sender's Comments: A female patient of unspecified age took the first dose of Vivotif vaccine with hot coffee for indication typhoid fever prophylaxis, which is considered as product administration error. It was unknown if the patient experienced any of adverse events due to Vivotif. Product administration error is considered as listed per company convention. The patient's medical history and concomitant medication details were not provided. Product administration error is not related to the suspect vaccine, but to a human factor. This case is considered as non-serious.
Comments: None